Novel Iron-Based Phosphate Binder Effective, Well-ToleratedRenal and Urology NewsIn the trial, which compared PA21 with sevelamer hydrochloride, 152 HD patients received a fixed-dose regimen of either PA21 (1.
Keryx Announces Positive Top-Line Results from Phase 3 Study; Medgenics Files ... - Proactive Investors USA & Canada